Option chain shows key data for Zealand Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Zealand Pharma.

Zealand Pharma (OTC:ZLDPF) Stock, Option Chain

ZEALAND PHARMA A/S ORD by Zealand Pharma A/S

Zealand Pharma

Overview

News

Short Interest

Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Comments

Zealand Pharma Option Chain

No option chain data available. Please try again later